Current award
In the most recent edition, Professor Kypros Nicolaides, a globally recognised pioneer in fetal medicine, was distinguished for his outstanding contribution to maternal–fetal health.
Prof. Nicolaides has transformed prenatal diagnosis and obstetric care, improving maternal and neonatal health outcomes worldwide
On 24 April 2026, the President of the Dexeus Mujer Foundation, Prof. Nikolaos Polyzos, presented the XX Dexeus Mujer Foundation Award to Prof. Kypros Nicolaides, in recognition of his exceptional scientific and clinical career and his pioneering contribution to the development of modern fetal medicine. This internationally oriented award is granted annually to an individual, team or institution for their contribution to the field of Health Sciences, particularly those related to women’s health. This international award is given each year to a person, team or institution for their contribution to the field of health sciences, with a particular focus on women.
Professor Kypros Nicolaides began his medical career in the United Kingdom, where he trained in Obstetrics and Foetal Medicine at King’s College Hospital in London. From the outset, his work focused on developing innovative prenatal diagnostic strategies, laying the foundations of contemporary fetal medicine. Likewise, he has been a pioneer in the application of minimally invasive foetal surgery techniques to treat severe pregnancy complications that pose significant risks to the foetus.
Among his most notable achievements is the introduction of first‑trimester combined screening for the detection of chromosomal abnormalities, now an international standard in pregnancy monitoring. His work has also been instrumental in the early identification and clinical management of obstetric complications such as preeclampsia, foetal growth restriction, and preterm birth.
He currently directs the Fetal Medicine Research Institute in London, from where he leads international programmes in research, training and collaboration aimed at improving pregnancy care and reducing maternal and fetal morbidity and mortality. He is also the founder and president of the Fetal Medicine Foundation, a charitable organisation dedicated to training, research and the dissemination of clinical standards in fetal medicine worldwide.
Valeria Tubita, from VHIR, was the winner of the scholarship in the latest edition, for her research into endometrial cancer
During the ceremony, the scholarship that the Dexeus Mujer Foundation awards annually to young researchers was also presented. This year’s winner was Valeria Tubita for a research project focused on evaluating the efficacy of combining anti-HER2 therapies and PARP inhibitors to enhance antitumour response and reduce the growth of HER2-positive endometrial cancer. Valeria Tubita is a postdoctoral researcher in the Biomedical Research in Gynaecology group at the Vall d’Hebron Research Institute (VHIR), where she focuses her work on the study of innovative therapies for endometrial cancer.
